High recent PrEP adherence with point-of-care urine tenofovirtesting and adherence counselling among young African women:results from the INSIGHT cohort
dc.contributor.author | Gati Mirembe, Brenda | |
dc.contributor.author | Donnell, Deborah | |
dc.contributor.author | Krows, Meighan | |
dc.contributor.author | Zwane, Zinhle | |
dc.contributor.author | Bukusi, Elizabeth | |
dc.contributor.author | Panchia, Ravindre | |
dc.contributor.author | Louw, Cheryl | |
dc.contributor.author | Mwelase, Noluthando | |
dc.contributor.author | Selepe, Pearl | |
dc.contributor.author | Senne, Melissa | |
dc.contributor.author | Naidoo, Logashvari | |
dc.contributor.author | Chihana, Rachel | |
dc.contributor.author | Kasaro, Margaret | |
dc.contributor.author | Nuwagaba-Biribonwoha, Harriet | |
dc.contributor.author | Kotze, Philip | |
dc.contributor.author | Gill, Katherine | |
dc.contributor.author | MacDonald, Pippa | |
dc.contributor.author | vanHeerden, Alastair | |
dc.contributor.author | Bosman, Shannon | |
dc.contributor.author | Jaggernath, Manjeetha | |
dc.contributor.author | du Preez, Phillip | |
dc.contributor.author | Ward, Amy | |
dc.contributor.author | Peters, Remco P H | |
dc.contributor.author | Delany-Moretlwe, Sinead | |
dc.contributor.author | Et.al | |
dc.date.accessioned | 2024-12-16T09:34:17Z | |
dc.date.available | 2024-12-16T09:34:17Z | |
dc.date.issued | 2024-12 | |
dc.description.abstract | Adolescent girls and young women (AGYW) account for two-thirds of new HIV infections in Africa. African AGYW have had high uptake of oral HIV pre-exposure prophylaxis (PrEP) but low adherence, which might be improved by point-of-care adherence monitoring with tailored counselling. From August 2022 to July 2023, we conducted a PrEP demonstration project with sexually active AGYW ages 16-30 years from 20 sites in South Africa, Eswatini, Kenya, Malawi, Uganda and Zambia. Participants were offered oral tenofovir-based PrEP at enrolment and followed up at 1, 3 and 6 months. PrEP adherence was assessed by a point-of-care qualitative lateral flow urine tenofovir (TFV) assay indicating PrEP use in the prior 4 days, which accompanied real-time adherence counselling that incorporated urine TFV results when testing was available (70.8% of month 1, 35.3% of month 3 and 83.9% of month 6 visits). We estimated overall adherence, correcting for missing test results, and analysed the association of having received urine TFV results at month 1 or 3 with subsequent urine TFV test positivity, using modified Poisson regression. Of the 3087 AGYW enrolled, the median age was 24 years (interquartile range 21-27), 75.7% were from South Africa, 2878 (93.2%) initiated PrEP at enrolment and 107 (3.5%) after enrolment. Visit retention was 92.0-96.2% for months 1, 3 and 6, and 2518 (90.1%) exited the study with a PrEP refill. Adherence, based on the point-of-care urine tenofovir test positivity rate, was estimated as 72%, 71% and 65% at months 1, 3 and 6, respectively. Women who received one prior urine TFV test had a 42% higher likelihood of a subsequent positive urine TFV test (adjusted odds ratio, OR = 1.42, 95% confidence interval, CI 1.27-1.60), and those having received two prior tests had a 67% higher likelihood (adjusted OR = 1.67; 95% CI 1.41-1.98). Observed HIV incidence was 1.38/100 person-years (95% CI 0.97-2.08). Oral PrEP uptake, recent adherence and persistence were high in a multisite cohort of young African women over 6 months of follow-up. The use of a novel point-of-care tenofovir assay with tailored real-time adherence counselling was associated with increased adherence to PrEP at subsequent visits, warranting further study. clinicaltrials.gov NCT05746065. | |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/9729 | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc | |
dc.title | High recent PrEP adherence with point-of-care urine tenofovirtesting and adherence counselling among young African women:results from the INSIGHT cohort | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal of the International AIDS Society - 2024 - Gati Mirembe - High recent PrEP adherence with point‐of‐care urine.pdf
- Size:
- 446.46 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: